Pharmaceutical giant charged with price-fixing in generic drug probe

Written By Ron Andruff

Pharmaceutical giant charged with price-fixing in generic drug probe

The charging document alleges that Glenmark and other pharmaceutical companies conspired to raise the price of the cholesterol drug pravastatin. It names Apotex as one of the companies with which Glenmark allegedly conspired. Apotex agreed to pay a $24 million penalty in May after admitting it had conspired with other companies to fix the price of prevastatin.

Ron Andruff
Previous

Drug prices steadily rise amid pandemic
Next

Number of people buying prescription medications outside U.S. could rise with unemployment